세계 홀 슬라이드 이미징 시장은 예측 기간(2023년-2030년) 동안 복합 연간 성장률(CAGR) 6.4%로 성장할 것으로 예측됩니다. 이 시장의 성장의 배경은 세계 컴퓨터 처리 능력의 향상이 있습니다. 강력한 컴퓨터 개발로 WSI 스캐너에서 생성되는 엄청난 이미지 처리 및 분석이 가능해졌습니다. 이미지 분석은 기술의 발전으로 더욱 빠르고 정확해졌습니다. 국립위생연구소(gov.)에 따르면 2023년 7월 병리의사, 병리부문, 연구자들 사이에서 홀 슬라이드 이미징의 이용이 증가하고 있습니다. 2018년과 2020년에 실시된 조사에 따르면, 기존의 유리 슬라이드에 대한 접근 유무에 관계없이 병리학자가 1차 진단을 내리는 편안함은 각각 54%에서 90%로, 23%에서 60%로 증가 했습니다. 이는 최첨단 광학계와 로봇 공학, 컴퓨터 처리 능력 향상, 데이터 전송 속도, 소프트웨어 개발, 클라우드 스토리지 솔루션 등 기술의 진보로 인한 점이 큽니다. 따라서 WSI는 원격 병리 검사, 컨설팅, 종양 보드, 슬라이드 보존, 여러 면역 조직 화학 염색과의 비교 등에 사용됩니다.
홀 슬라이드 이미징 시장에서는 스캐너의 하위 부문이 큰 점유율을 차지할 것으로 예상됩니다. 이 부문의 성장은 세계에서 디지털 병리학에 대한 수요가 증가하고 있기 때문입니다. 디지털 병리학 솔루션에 대한 수요 증가는 슬라이드에 대한 원격 액세스, 텔레파솔로지, 공동 분석 등 디지털 병리학의 장점 중 일부일 뿐입니다. 병리학자와 연구자들은 NanoZoomer S20MD와 같은 스캐너를 활용하여 디지털 퍼솔로지의 혜택을 누릴 수 있습니다.
세계 홀 슬라이드 이미징 시장은 북미(미국, 캐나다), 유럽(영국, 이탈리아, 스페인, 독일, 프랑스, 기타 유럽), 아시아태평양(인도, 중국, 일본, 한국, 기타 아시아 지역), 세계 기타 지역(중동 및 아프리카, 라틴아메리카)으로 지역별로 구분됩니다. 그 중에서도 아시아태평양은 홀 슬라이드 이미징의 장점에 대한 인식이 높아지고 있는 것 외에도 인도나 중국 등 일부 국가의 인구 기반의 넓이가 이 지역 시장 성장에 기여하고 있음 부터 전 세계에서 큰 점유율을 차지할 것으로 예상됩니다.
모든 지역 중에서 북미는 예측 기간 동안 상당한 복합 연간 성장률(CAGR)로 성장할 것으로 예상됩니다. 이 지역의 성장은 세계 원격 병리학과 원격 세포학의 발전으로 인한 것입니다. 원격 세포 진단 평가에서 높은 감도와 특이성을 달성한 연구의 성공은 건강 관리 개선에서 텔레파솔로지의 중요성을 강조합니다. 원격 세포 진단을 포함한 텔레파솔로지는 병리학자가 원격지에서 디지털 슬라이드에 액세스하고 해석할 수 있게 하며, 특히 전문가가 적은 지역에서 진단 및 컨설팅을 용이하게 합니다. MDPI에 따르면(2023년) 10월, LungenClinic Grosshansdorf에서 239명의 환자에게 실시된 314개의 Rapid Remote Online Cytological Evaluations(154의 임프린트 세포 진단, 143의 세침 흡인, 17의 브러시 세포 진단)을 분석 했습니다. 원격 세포 진단에 의한 현장 평가에서는 소요 시간을 기록하고 소견을 세포,조직학적 진단 및 최종 진단과 비교하였습니다. 그 결과, 세포학적 양성 86례, 악성 190례, 불명 38례의 진단이 기록되었습니다. 진단이 불분명했던 37개 검체를 제외하고는 최종 진단에 대한 감도율은 90.5%, 특이도율은 98.5%, 정확한 분류율은 92.4%였습니다. 악성 종양의 세포학적 검출의 감도율은 미세침 흡인으로 76.1%, 소견 불명의 37 검체를 제외하면 92.5%였습니다.
Global Whole Slide Imaging Market Size, Share & Trends Analysis Report by Technology (Scanners, IT Infrastructure, and ViewerImage Management System), by Application (Telepathology, Cytopathology, Immunohistochemistry, Hematopathology, and Others), and by End-User (Academic Institute, Hospitals and Healthcare Institutions, Pharmaceutical Research and Contract Research Organizations (CROs), and Others), Forecast Period (2023-2030)
The global whole slide imaging market is anticipated to grow at a CAGR of 6.4% during the forecast period (2023-2030). The market's growth is attributed to the increased computer processing power across the globe. The development of powerful computers has made it possible to process and analyze enormous images generated by WSI scanners. Image analysis has grown more rapid and precise as a result of technology. According to the National Institute of Health (gov.), in July 2023, the use of whole slide imaging has increased among pathologists, pathology departments, and research scientists. A survey conducted in 2018 and 2020 found that the comfort of pathologists to make a primary diagnosis with or without access to traditional glass slides increased from 54% to 90%, and from 23% to 60%, respectively. This is largely attributed to advancements in technology, including state-of-the-art optics and robotics, increased computer processing power, data transfer speeds, software development, and cloud storage solutions. As such, WSI has been used for telepathology, consultation, tumor boards, archiving slides, and comparisons with multiple immunohistochemical staining.
The global whole slide imaging market is segmented on the technology, application, and end-user. Based on the technology, the market is sub-segmented into scanners, it infrastructure, and viewer image management system. Based on the application, the market is sub-segmented into telepathology, cytopathology, immunohistochemistry, hematopathology, and others. Furthermore, on the basis of end-user, the market is sub-segmented into academic institute, hospitals and healthcare institutions, pharmaceutical research and contract research organizations (CROs), and others. The cytopathology subcategory is expected to capture a significant portion of the market share within the application segment. The increasing population base prone to numerous diseases. Cytopathology is a specialized diagnostic procedure that examines individual cells removed from tissues to determine the source and nature of a disease.
Among the technology, the scanners sub-segment is expected to hold a considerable share of the global whole slide imaging market. The segmental growth is attributed to the increased demand for digital pathology across the globe. Increase in demand for digital pathology solutions remote access to slides, telepathology, and collaborative analysis are merely a few of the advantages of digital pathology. Pathologists and researchers can benefit from digital pathology by utilizing scanners such as the NanoZoomer S20MD. For instance, in March 2023, Hamamatsu Photonics, released the new NanoZoomer S20MD Slide scanner system (C16300-21MDEU).The NanoZoomer S20MD Slide scanner system offers excellent image quality and rapid throughput, scanning 20 slides in 15 minutes. It is designed with the same pixel pathway as the high-end model and includes image acquisition and viewing software. It is additionally compliant with IVDR (EU), UKCA (UK) and IvDO (CH) regulations.
The global whole slide imaging market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Asia-Pacific is anticipated to hold a prominent share of the market across the globe, owing to rising awareness of the benefits of whole slide imaging, in addition to an extensive population base in some countries such as India and China, have contributed to the region's market growth.
Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to the telepathology and tele-cytology development across the globe. The study's success in reaching high sensitivity and specificity rates in remote cytological evaluations emphasizes the significance of telepathology in healthcare improvement. Telepathology, that involve tele-cytology, enables pathologists to remotely access and interpret digital slides, making it easier to provide diagnosis and consultations, particularly in areas where specialist expertise is scarce. According to the MDPI, in October 2023, the prospective study analyzed 314 Rapid Remote Online Cytological Evaluations (154 imprint cytologies, 143 fine needle aspirations and 17 brush cytologies) performed on 239 patients at the LungenClinic Grosshansdorf. During on-site evaluation via tele-cytology, the time requirement was recorded and the findings were compared with the cyto-/histological and final diagnoses. The results showed that 86 cytological benign, 190 malignant and 38 unclear diagnoses were recorded. Excluding the 37 specimens with unclear diagnoses, the sensitivity rate was 90.5%, the specificity rate was 98.5% and the correct classification rate was 92.4% with regard to the final diagnosis. The sensitivity rate for the cytological detection of malignant tumors was 76.1% for fine-needle aspirations and 92.5% when excluding the 37 specimens with unclear findings.
The major companies serving the whole slide imaging market include Leica Microsystems GmbH, Olympus Corp. Philips International B.V., NIKON CORP., Visiopharm A/S, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in September 2022, Infinitt collaborated with Hamamatsu, offered improved integration with NanoZoomers, allowing laboratories and pathologists to review slides in an end-to-end operational workflow. Furthermore, the integration of IDPS with LIS will allow pathologists to work more efficiently in a digital environment.